Tumor size and prognosis in aggressively treated osteosarcoma.P. Bieling, K. Winkler, Ralf Romanowski et al.|Journal of Clinical Oncology|1996Cited by 279
Die prognostische Bedeutung des Tumorvolumens beim Osteosarkom unter neoadjuvanter ChemotherapieNosheen Rehan, K. Winkler, P. Bieling et al.|Klinische Pädiatrie|1993Cited by 16
Plerixafor Plus G-CSF Resulted In Similar Cost But More Predictable Days Of Apheresis Compared To Chemotherapy Plus G-CSF For Mobilization Of Autologous Hematopoietic Stem CellsPaul Shaughnessy, Peter A. McSweeney, Miguel Islas‐Ohlmayer et al.|Transplantation and Cellular Therapy|2010Cited by 2
Morphological investigation of tumor growth and distribution of viable tumour areas in osteosarcomas after chemotherapy.G. Delling, K. Winkler, M Pompesius-Kempa et al.|PubMed|1990Cited by 1